Literature DB >> 12032334

Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.

S-L Catherine Jin1, Marco Conti.   

Abstract

Lipopolysaccharide (LPS) stimulation of the innate immune response requires the activation of signaling cascades that culminate in the synthesis and secretion of proinflammatory cytokines. Given the inhibitory effects of phosphodiesterase (PDE) inhibitors on LPS-induced cytokine production, we have investigated LPS responses in mice deficient in PDE4 (type 4 cAMP-specific PDE)-B and PDE4D. LPS stimulation of mouse peripheral leukocytes induced PDE4B mRNA accumulation and increased PDE4 activity. This response was completely absent in mice deficient in PDE4B but not PDE4D. LPS induction of tumor necrosis factor-alpha secretion by circulating leukocytes was decreased by approximately 90% in mice deficient in PDE4B but not in mice lacking PDE4D. The impaired LPS response was evident regardless of the LPS dose used for stimulation and was associated with a more than 90% decrease in tumor necrosis factor-alpha mRNA accumulation. A decreased responsiveness to LPS was also present in other inflammatory cells, including peritoneal and lung macrophages. These findings demonstrate that PDE4B gene activation by LPS constitutes a feedback regulation essential for an efficient immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032334      PMCID: PMC124305          DOI: 10.1073/pnas.122041599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

Review 1.  Evaluation of CD14 in host defence.

Authors:  P Antal-Szalmás
Journal:  Eur J Clin Invest       Date:  2000-02       Impact factor: 4.686

2.  Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs.

Authors:  J de Rooij; H Rehmann; M van Triest; R H Cool; A Wittinghofer; J L Bos
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

3.  T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.

Authors:  N A Glavas; C Ostenson; J B Schaefer; V Vasta; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 4.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

Authors:  W A Stack; S D Mann; A J Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Forbes; M A Kamm
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

Review 6.  Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

Authors:  T J Torphy
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

Review 7.  Gating by cyclic AMP: expanded role for an old signaling pathway.

Authors:  R Iyengar
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.

Authors:  D Fekade; K Knox; K Hussein; A Melka; D G Lalloo; R E Coxon; D A Warrell
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

9.  Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.

Authors:  M W Verghese; R T McConnell; J M Lenhard; L Hamacher; S L Jin
Journal:  Mol Pharmacol       Date:  1995-06       Impact factor: 4.436

10.  The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.

Authors:  J Semmler; H Wachtel; S Endres
Journal:  Int J Immunopharmacol       Date:  1993-04
View more
  110 in total

1.  Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.

Authors:  Leila Gobejishvili; Shirish Barve; Katja Breitkopf-Heinlein; Yan Li; JingWen Zhang; Diana V Avila; Steven Dooley; Craig J McClain
Journal:  J Pharmacol Exp Ther       Date:  2013-07-25       Impact factor: 4.030

2.  Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice.

Authors:  Biyan Duan; Richard Davis; Eva L Sadat; Julie Collins; Paul C Sternweis; Dorothy Yuan; Lily I Jiang
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 3.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

4.  Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.

Authors:  Seiko Susuki-Miyata; Masanori Miyata; Byung-Cheol Lee; Haidong Xu; Hirofumi Kai; Chen Yan; Jian-Dong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 5.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.

Authors:  Hao Huang; Qian Hong; Hong-Ling Tan; Cheng-Rong Xiao; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

7.  siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.

Authors:  Hao Cheng; Zhifang Wu; Xiaoyun He; Qingzhen Liu; Hongbin Jia; Yan Di; Qing Ji
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

8.  The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).

Authors:  Moses Xie; Brigitte Blackman; Colleen Scheitrum; Delphine Mika; Elise Blanchard; Tao Lei; Marco Conti; Wito Richter
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

9.  Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury.

Authors:  Christopher M Whitaker; Eric Beaumont; Michael J Wells; David S K Magnuson; Michal Hetman; Stephen M Onifer
Journal:  Neurosci Lett       Date:  2008-04-08       Impact factor: 3.046

Review 10.  The role of phosphodiesterases in schizophrenia : therapeutic implications.

Authors:  Judith A Siuciak
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.